Curve Therapeutics Further Strengthens Leadership Team With the Appointment of Andre Hoekema as New Chair of Board

PR NewswireOct 2 03:30 ET

Express News | Excellos, Cell Therapy Contract And Development Manufacturing Organization Member Of Blood Centers Of America Has Been Selected To Manufacture Galapagos' Car-t Cell Therapy Candidate, GLPG5101, For Its Recently FDA-Cleared ATALANTA-1 Study For...

BenzingaOct 1 06:07 ET

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos' CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area

BusinesswireOct 1 06:00 ET

Galapagos Announces Major Stake by EcoR1 Capital

TipRanksSep 16 16:37 ET

Galapagos Receives Transparency Notification From EcoR1 Capital, Now Holding 10.19% Of Galapagos' Voting Rights Through Acquisition Of 6.71M Shares; EcoR1 Capital Crosses 10% Threshold As Of September 10, 2024

BenzingaSep 16 16:02 ET

Galapagos Analyst Ratings

BenzingaSep 9 08:51 ET · Ratings